One of the commonly observed clinical tumor markers for screening, e.g., the carcinoembryonic antigen (CEA), has been applied for the diagnosis of tumors including breast [5], colon [6], lung [7], pancreatic [8], cervical and ovarian tumors [9]. This evidence concerns the gene CEACAM5 and neoplasm.